Compounding Problems

by Searcy Denney Scarola Barnhart & Shipley
Contact

In the production of pharmaceutical drugs there are large scale drug manufacturers which produce brand name and generic drugs, and there are compound pharmacies which are specialty pharmacies made to fill out unique orders for clients using already existing medications. Drug manufacturers fall under FDA standards and regulations, while compounding pharmacies fall under the state board of pharmacy’s regulatory jurisdiction. The primary uses of a traditional compound pharmacy are if a patient needs a very specific dose of a medication or if a patient needs to convert a normally solid medication into a liquid.

In recent years, drug manufacturers have been outsourcing their work to these compounding pharmacies. This outsourcing massively expanded the scope of compounding pharmacies beyond their traditional role. Because these compounding pharmacies are not under the jurisdiction of the FDA but rather the state board of pharmacy, some of these compound pharmacies can have less than satisfactory producing conditions for this outsourcing process. This was made apparent to the FDA and the world in general in 2012 when there was a massive fungal meningitis outbreak linked to the unsanitary manufacturing conditions of the New England Compounding Center (NECC). The outbreak left many patients horribly ill, and in some cases, dead. In response to this tragedy, Congress passed the Drug Quality and Security Act in November of 2012. This placed compounding pharmacies that are classified as out sourcing facilities under the FDA’s regulatory oversight.

But even after the NECC tragedy, drug companies are still trying to outsource production of their drugs while compounding pharmacies are still not raising their standards for production. In 2013, at least 30 compound pharmacies were cited for unsanitary conditions. These unsanitary conditions included instances of black particles floating in supposedly sterile medications. In the beginning of March 2014, three more compounding pharmacies were cited for unsanitary conditions.

This has also led to more compounding pharmacies trying to circumvent FDA control entirely. In order for a pharmacy to be classified as a traditional compounding pharmacy – thus not falling under the FDA’s regulatory umbrella, the pharmacy must create tailored medication in response to specific and individual prescriptions. Two out of the three companies cited in 2014, Nora Apothecary and Alternative Therapies Inc. and Wedgeworth Village Pharmacy Inc., were also recently cited by the FDA for making products without specific and individual prescriptions. This means that these compounding pharmacies were not exempt and were subject to FDA regulation. The FDA subsequently found that the sterilization procedures and overall sanitary condition of these companies’ facilities were severely lacking. This blatant attempt to dodge regulation is nothing new for the compounding pharmacy industry, as the FDA has run into repeated issues trying to get access to some compounder’s pharmacies and records.

Compounding pharmacies offer a much needed service to individuals who need tailored drugs. However, this does not excuse their attempts at skirting FDA oversight as  their unregulated and unsafe conditions in their factories can seriously harm patients. Thankfully, all of the companies that were found to have substandard conditions are not allowed to reopen until their factories are made safe and sanitary. Regardless,  the fact that these compounding pharmacies were able to manufacture and sell products that did not meet FDA standards for such a long period of time is disturbing.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Searcy Denney Scarola Barnhart & Shipley | Attorney Advertising

Written by:

Searcy Denney Scarola Barnhart & Shipley
Contact
more
less

Searcy Denney Scarola Barnhart & Shipley on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.